Company

Paterna Biosciences Inc.

Paterna Biosciences develops in vitro spermatogenesis technology for male infertility treatment.

About

Founded in 2020 and based in Salt Lake City, Paterna Biosciences is developing in vitro spermatogenesis technology using adult testicular stem cells. The technology is intended to support fertility clinics and assisted reproductive treatments. In October 2024, it raised USD 6.000 mn in seed funding led by Springtide Ventures, with Divergent Capital, Freya Ventures, Seaside Ventures and Utah Innovation Fund participating.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in